Addition of Nimotuzumab to Standard TPF Regimen in Locally Advanced Head and Neck Cancer: A Single Institutional Study

<div>Kaplan Meier Curve of progression-free survival (months) according to subsite (blue line represents oral cavity, green line represents hypopharynx, and yellow represents oropharynx).</div>

Journal of Oncology

fig2

Figure 2

Figure 2: Addition of Nimotuzumab to Standard TPF Regimen in Locally Advanced Head and Neck Cancer: A Single Institutional Study 